Jonathan Hauptman

XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

Jarl Torgerson, Jonathan Hauptman, Mark Boldrin et al. · Diabetes Care · 2004 · 1.9K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat

Michael Davidson, Jonathan Hauptman, Mario DiGirolamo et al. · JAMA · 1999 · 945 citations

Agriculture, Pharmacology, Pharmacotherapy +17

Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans

Brian Finan, Tao Ma, Nickki Ottaway et al. · Science Translational Medicine · 2013 · 675 citations

Medicine, Pharmacokinetics, Pharmacology +16

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Priscilla Hollander, Steven C. Elbein, Irl B. Hirsch et al. · Diabetes Care · 1998 · 657 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Orlistat on Weight and Body Composition in Obese Adolescents

Jean‐Pierre Chanoine, Sarah Hampl, Craig L. Jensen et al. · JAMA · 2005 · 624 citations

Agriculture, Pediatrics, Pharmacotherapy +17